ANAPTYSBIO INC (ANAB) Earnings History & Surprises
NASDAQ:ANAB • US0327241065
59.7 USD
+4.29 (+7.74%)
At close: Mar 9, 2026
63.39 USD
+3.69 (+6.18%)
Pre-Market: 3/10/2026, 5:48:54 AM
Past quarterly earnings results for ANAPTYSBIO INC (ANAB), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateMay 4, 2026
PeriodQ4 / 2025
EPS Estimate$0.96
Revenue Estimate93.892M
Last Reported
Release DateMar 9, 2026
PeriodQ3 / 2025
EPS Reported$0.52
EPS Surprise 135.42%
Revenue Surprise 373.21%
Beat Rate
75%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 0.52 | -1.47 | 135.42% | 145.61% | 76.32M | 16.128M | 373.21% | 154.26% |
| Q2 2025 | -1.34 | -1.57 | 14.78% | 21.64% | 22.263M | 11.783M | 88.94% | 102.93% |
| Q1 2025 | -1.28 | -1.28 | -0.12% | 21.95% | 27.771M | 15.579M | 78.26% | 286.84% |
| Q4 2024 | -0.72 | -1.65 | 56.40% | 54.72% | 43.113M | 7.923M | 444.15% | 378.77% |
| Q3 2024 | -1.14 | -1.68 | 32.14% | 19.15% | 30.017M | 7.01M | 328.20% | 804.67% |
| Q2 2024 | -1.71 | -1.01 | -69.51% | -14.00% | 10.971M | 24.787M | -55.74% | 217.08% |
| Q1 2024 | -1.64 | -1.60 | -2.69% | -3.80% | 7.179M | 4.047M | 77.39% | 422.49% |
| Q4 2023 | -1.59 | -1.63 | 2.65% | -70.97% | 9.005M | 2.273M | 296.17% | 32.23% |
| Q3 2023 | -1.41 | -1.83 | 22.95% | -19.49% | 3.318M | 2.481M | 33.74% | 157.21% |
| Q2 2023 | -1.50 | -1.73 | 13.36% | -30.43% | 3.46M | 3.388M | 2.13% | 183.61% |
| Q1 2023 | -1.58 | -1.07 | -47.81% | -20.61% | 1.374M | 3.647M | -62.33% | 41.65% |
| Q4 2022 | -0.93 | -0.98 | 4.74% | 17.70% | 6.81M | 6.967M | -2.25% | 574.26% |
| Q3 2022 | -1.18 | -0.74 | -59.94% | -391.67% | 1.29M | 10.55M | -87.77% | -93.82% |
| Q2 2022 | -1.15 | -1.04 | -10.35% | -5,650.00% | 1.22M | 4.808M | -74.63% | -95.94% |
| Q1 2022 | -1.31 | -1.01 | -29.08% | -98.48% | 970K | 5.155M | -81.18% | -91.38% |
| Q4 2021 | -1.13 | 2.62 | -143.06% | -194.17% | 1.01M | 113.1M | -99.11% | -98.32% |
| Q3 2021 | -0.24 | -0.93 | 74.10% | 72.41% | 20.89M | 6.808M | 206.84% | - |
| Q2 2021 | -0.02 | -0.11 | 81.70% | 97.47% | 30.03M | 29.459M | 1.94% | - |
| Q1 2021 | -0.66 | -0.70 | 5.95% | -120.00% | 11.25M | 9.577M | 17.47% | -25.00% |
| Q4 2020 | 1.20 | 1.42 | -15.48% | - | 60M | 65.28M | -8.09% | - |
| Q3 2020 | -0.87 | -0.74 | -18.25% | - | 1.7M | -100.00% | - | |
| Q2 2020 | -0.79 | -0.76 | -3.29% | - | 2.368M | -100.00% | - | |
| Q1 2020 | -0.30 | -0.64 | 53.31% | - | 15M | 6.375M | 135.29% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
51.62%
Max EPS beat (4)
135.42%
Min EPS beat (4)
-0.12%
Revenue beat statistics
Revenue beat (4)
4
Average Revenue beat (4)
246.14%
Max Revenue beat (4)
444.15%
Min Revenue beat (4)
78.26%
Analysis
In the last 4 quarters, ANAB has beaten EPS estimates in 3 out of 4 releases
ANAB has consistently beaten revenue estimates in all past 4 earnings releases
In the last 4 quarters, ANAB has beaten the EPS estimates by 51.6% on average.
In the last 4 quarters, ANAB has beaten the revenue estimates by 246.1% on average.
ANAPTYSBIO INC / ANAB Earnings FAQ
What is the most recent earnings date for ANAB stock?
ANAPTYSBIO INC (ANAB) last reported earnings on 3/9/2026.
Can you provide information on whether ANAPTYSBIO INC beat earnings estimates in the last quarter?
ANAPTYSBIO INC (ANAB) beat EPS estimates and beat revenue estimates in the most recent quarter.
What percentage of the time does ANAB stock beat earnings estimates?
In the last 4 quarters, ANAPTYSBIO INC (ANAB) has beaten EPS estimates in 3 out of 4 releases.